RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis
Open Access
- 18 February 2005
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (5), 456-463
- https://doi.org/10.1038/sj.cgt.7700815
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Short hairpin type of dsRNAs that are controlled by tRNAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cellsNucleic Acids Research, 2003
- Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5Proceedings of the National Academy of Sciences, 2002
- Retroviral delivery of small interfering RNA into primary cellsProceedings of the National Academy of Sciences, 2002
- Development and application of siRNA expression vectorNucleic Acids Symposium Series, 2002
- Stable suppression of tumorigenicity by virus-mediated RNA interferenceCancer Cell, 2002
- Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cellsNature Biotechnology, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cellsGenes & Development, 2002
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998
- Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.Molecular and Cellular Biology, 1993